Good morning, Broadsheet readers! The Fortune 500 loses a female CEO, shareholders are still watching gender diversity closely, and Fortune investigates the risky business of breast implants. Have a lovely Tuesday.
-A different kind of health concern. Today’s essay comes from our Fortune colleague Maria Aspan:
Early last year, one of my friends had a terrifying conversation with her doctor. In 2014, after her mother died of cancer and my friend discovered she carried a genetically high risk of eventually developing the disease, she had decided to protect herself with a preventative double mastectomy and reconstruction—“the Angelina Jolie surgery,” as
Read more Source: fortune.com